跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
Activation of PERK in ET-1- and thrombin-induced pulmonary fibroblast differentiation: Inhibitory effects of curcumin
Yen Chou Chen,
Bing Chang Chen
,
Huei Mei Huang
, Shin Hua Lin,
Chien-Huang Lin
醫學科學研究所
臺北醫學大學附設醫院
臺北醫學大學癌症轉譯研究中心
胸腔內科
呼吸治療學系
新藥研發產業博士學位學程
國際醫學研究碩博士學位學程
臺北醫學大學細胞治療與再生醫學研究中心
細胞治療與再生醫學國際博士學位學程
代謝與肥胖科學研究所
臺北醫學大學胸腔醫學研究中心
應用流行病學碩士學位學程
轉譯醫學博士學位學程
中草藥臨床藥物研發博士學位學程
研究成果
:
雜誌貢獻
›
文章
›
同行評審
14
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Activation of PERK in ET-1- and thrombin-induced pulmonary fibroblast differentiation: Inhibitory effects of curcumin」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Phosphotransferase
100%
Fibroblast
100%
Thrombin
100%
Endothelin 1
100%
Curcumin
100%
WI-38
60%
Endoplasmic Reticulum Stress
40%
Prothrombin
40%
Vimentin
20%
Amino Terminal Sequence
20%
Phosphotransferase Inhibitor
20%
Small Interfering RNA
20%
Immunohistochemistry
20%
Pulmonary Fibrosis
20%
Smooth Muscle Actin
10%
Western Blot
10%
Lung Fibroblast
10%
Fibroblast Cell Line
10%
Intraperitoneal Drug Administration
10%
CCAAT Enhancer Binding Protein
10%
Glycogen Synthesis
10%
Thapsigargin
10%
Bleomycin-Induced Pulmonary Fibrosis
10%
Stress Kinase
10%
Immunoglobulin Binding
10%
Mitogen-Activated Protein Kinase
10%
Antibodies
10%
Biochemistry, Genetics and Molecular Biology
Fibroblast
100%
Thrombin
100%
Kinase
100%
Phosphotransferase
100%
Endothelin 1
100%
WI-38
50%
Endoplasmic Reticulum Stress
33%
Small Interfering RNA
16%
N-Terminus
16%
Vimentin
16%
Ccaat-Enhancer-Binding Proteins
8%
Glycogenesis
8%
Bleomycin
8%
Stress Kinase
8%
Binding Immunoglobulin Protein
8%
Western Blot
8%
Monospecific Antibody
8%
Actin
8%
Mitogen-Activated Protein Kinase
8%
Pharmacology, Toxicology and Pharmaceutical Science
Curcumin
100%
Phosphotransferase
100%
Thrombin
100%
Endothelin 1
100%
Prothrombin
36%
Small Interfering RNA
18%
Phosphotransferase Inhibitor
18%
Vimentin
18%
Lung Fibrosis
18%
Western Blot
9%
Mitogen Activated Protein Kinase
9%
Immunoglobulin
9%
Intraperitoneal Injection
9%
Smooth Muscle Actin
9%
CCAAT Enhancer Binding Protein
9%
Bleomycin-Induced Pulmonary Fibrosis
9%
Antibodies
9%
Thapsigargin
9%